Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis-Reference-Cited by-同舟云学术

Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis

Published:2014-12 Issue:6 Volume:134 Page:1293-1300
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Hamilton Jennifer D.,Suárez-Fariñas Mayte,Dhingra Nikhil,Cardinale Irma,Li Xuan,Kostic Ana^ORCID,Ming Jeffrey E.,Radin Allen R.,Krueger James G.,Graham Neil,Yancopoulos George D.,Pirozzi Gianluca,Guttman-Yassky Emma

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference40 articles.

1. A population-based survey of eczema prevalence in the United States;Hanifin;Dermatitis,2007

2. The direct and indirect cost burden of atopic dermatitis: an employer-payer perspective;Fowler;Manag Care Interface,2007

3. The socioeconomic impact of atopic dermatitis in the United States: a systematic review;Mancini;Pediatr Dermatol,2008

4. Quality of life of children with atopic dermatitis and their families;McKenna;Curr Opin Allergy Clin Immunol,2008

5. Quality-of-life outcomes and measurement in childhood atopic dermatitis;Chamlin;Immunol Allergy Clin North Am,2010

Cited by 363 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diversity of atopic dermatitis and selection of immune targets;Annals of Allergy, Asthma & Immunology;2024-02

2. Tryptophan, an important link in regulating the complex network of skin immunology response in atopic dermatitis;Frontiers in Immunology;2024-01-22

3. Genomic Profiling of the Overlap Phenotype between Psoriasis and Atopic Dermatitis;Journal of Investigative Dermatology;2024-01

4. Effect of abrocitinib on skin biomarkers in patients with moderate‐to‐severe atopic dermatitis;Allergy;2023-12-18

5. Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE– and Institute of Medicine–based recommendations;Annals of Allergy, Asthma & Immunology;2023-12